Vor Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	396.49	81.95	31.36	57.71	119.8
Short-Term Investments	58.72	9.98	105.82	172.54	87.67
Cash & Short-Term Investments	455.21	91.93	137.18	230.25	207.47
Cash Growth	395.19%	-32.99%	-40.42%	10.98%	323.35%
Other Current Assets	3.07	6.99	3.63	6.71	6.93
Total Current Assets	458.11	96.51	140.8	236.95	214.4
Net Property, Plant & Equipment	3.47	41.59	50.1	57.08	22.52
Other Long-Term Assets	2.38	2.38	7.23	5.34	5.67
Total Assets	464.13	142.89	198.13	299.37	242.59
Accounts Payable	5.13	1.51	0.82	1.77	1.55
Accrued Expenses	19.76	12.89	10.88	7.89	6.34
Current Portion of Leases	0.28	4.22	3.83	3.27	1.84
Other Current Liabilities	-	-	0.05	0.19	0.43
Total Current Liabilities	25.17	18.61	15.57	13.12	10.15
Long-Term Leases	2.72	27.62	31.83	35.64	16.17
Other Long-Term Liabilities	600.55	-	-	-	-
Total Long-Term Liabilities	603.27	27.62	31.83	35.64	16.17
Total Liabilities	628.44	46.23	47.4	48.76	26.33
Common Stock	0.02	0.01	0.01	0.01	0
Additional Paid-in Capital	988.6	553.62	490.87	473.59	346.38
Accumulated Other Comprehensive Income	0.04	0.02	-0.08	-0.77	-
Retained Earnings	-1,153	-456.99	-340.08	-222.22	-130.12
Total Common Shareholders' Equity	-164.31	96.66	150.72	250.61	216.26
Shareholders' Equity	-164.31	96.66	150.72	250.61	216.26
Total Liabilities & Equity	464.13	142.89	198.13	299.37	242.59
Total Debt	3	31.83	35.66	38.91	18.01
Net Cash (Debt)	452.21	60.1	101.52	191.33	189.46
Net Cash Growth	652.48%	-40.80%	-46.94%	0.99%	516.86%
Net Cash Per Share	45.81	17.49	30.22	96.75	113.33
Book Value	-164.31	96.66	150.72	250.61	216.26
Book Value Per Share	-16.64	28.14	44.86	126.72	129.37
Tangible Book Value	-164.31	96.66	150.72	250.61	216.26
Tangible Book Value Per Share	-16.64	28.14	44.86	126.72	129.37

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q